- Home
- GBIO vs MLSS Comparison
GBIO vs MLSS Comparison
Compare GBIO & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- MLSS
- Stock Information
- Founded
- GBIO 2016
- MLSS 1989
- Country
- GBIO United States
- MLSS United States
- Employees
- GBIO N/A
- MLSS N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- GBIO Health Care
- MLSS Health Care
- Exchange
- GBIO Nasdaq
- MLSS Nasdaq
- Market Cap
- GBIO 41.2M
- MLSS 42.4M
- IPO Year
- GBIO 2020
- MLSS 1995
- Fundamental
- Price
- GBIO $5.19
- MLSS $0.43
- Analyst Decision
- GBIO Buy
- MLSS Buy
- Analyst Count
- GBIO 4
- MLSS 1
- Target Price
- GBIO $10.67
- MLSS $1.25
- AVG Volume (30 Days)
- GBIO 68.4K
- MLSS 202.8K
- Earning Date
- GBIO 11-05-2025
- MLSS 11-14-2025
- Dividend Yield
- GBIO N/A
- MLSS N/A
- EPS Growth
- GBIO N/A
- MLSS N/A
- EPS
- GBIO N/A
- MLSS N/A
- Revenue
- GBIO $21,230,000.00
- MLSS $9,083,205.00
- Revenue This Year
- GBIO N/A
- MLSS $16.06
- Revenue Next Year
- GBIO N/A
- MLSS $14.73
- P/E Ratio
- GBIO N/A
- MLSS N/A
- Revenue Growth
- GBIO 61.15
- MLSS 7.84
- 52 Week Low
- GBIO $3.00
- MLSS $0.35
- 52 Week High
- GBIO $25.70
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- GBIO 33.89
- MLSS 45.53
- Support Level
- GBIO $5.10
- MLSS $0.35
- Resistance Level
- GBIO $6.47
- MLSS $0.44
- Average True Range (ATR)
- GBIO 0.24
- MLSS 0.04
- MACD
- GBIO -0.12
- MLSS 0.00
- Stochastic Oscillator
- GBIO 11.68
- MLSS 58.15
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.